Circius Pharma ApS — Credit Rating and Financial Key Figures

Circius Pharma ApS (CVR number: 42447641) is a company from GENTOFTE. The company recorded a gross profit of 2770.4 kDKK in 2023. The operating profit was -2183.4 kDKK, while net earnings were -2242.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was -26.5 %, which can be considered poor and Return on Equity (ROE) was -49.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 51.6 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Circius Pharma ApS's liquidity measured by quick ratio was 2.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.